Cargando…
Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells
Ran Binding Protein 9 (RanBP9, also known as RanBPM) is an evolutionary conserved scaffold protein present both in the nucleus and the cytoplasm of cells whose biological functions remain elusive. We show that active ATM phosphorylates RanBP9 on at least two different residues (S181 and S603). In re...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951294/ https://www.ncbi.nlm.nih.gov/pubmed/26943034 http://dx.doi.org/10.18632/oncotarget.7813 |
_version_ | 1782443678095114240 |
---|---|
author | Palmieri, Dario Scarpa, Mario Tessari, Anna Uka, Rexhep Amari, Foued Lee, Cindy Richmond, Timothy Foray, Claudia Sheetz, Tyler Braddom, Ashley Burd, Christin E. Parvin, Jeffrey D. Ludwig, Thomas Croce, Carlo M. Coppola, Vincenzo |
author_facet | Palmieri, Dario Scarpa, Mario Tessari, Anna Uka, Rexhep Amari, Foued Lee, Cindy Richmond, Timothy Foray, Claudia Sheetz, Tyler Braddom, Ashley Burd, Christin E. Parvin, Jeffrey D. Ludwig, Thomas Croce, Carlo M. Coppola, Vincenzo |
author_sort | Palmieri, Dario |
collection | PubMed |
description | Ran Binding Protein 9 (RanBP9, also known as RanBPM) is an evolutionary conserved scaffold protein present both in the nucleus and the cytoplasm of cells whose biological functions remain elusive. We show that active ATM phosphorylates RanBP9 on at least two different residues (S181 and S603). In response to IR, RanBP9 rapidly accumulates into the nucleus of lung cancer cells, but this nuclear accumulation is prevented by ATM inhibition. RanBP9 stable silencing in three different lung cancer cell lines significantly affects the DNA Damage Response (DDR), resulting in delayed activation of key components of the cellular response to IR such as ATM itself, Chk2, γH2AX, and p53. Accordingly, abrogation of RanBP9 expression reduces homologous recombination-dependent DNA repair efficiency, causing an abnormal activation of IR-induced senescence and apoptosis. In summary, here we report that RanBP9 is a novel mediator of the cellular DDR, whose accumulation into the nucleus upon IR is dependent on ATM kinase activity. RanBP9 absence hampers the molecular mechanisms leading to efficient repair of damaged DNA, resulting in enhanced sensitivity to genotoxic stress. These findings suggest that targeting RanBP9 might enhance lung cancer cell sensitivity to genotoxic anti-neoplastic treatment. |
format | Online Article Text |
id | pubmed-4951294 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-49512942016-07-21 Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells Palmieri, Dario Scarpa, Mario Tessari, Anna Uka, Rexhep Amari, Foued Lee, Cindy Richmond, Timothy Foray, Claudia Sheetz, Tyler Braddom, Ashley Burd, Christin E. Parvin, Jeffrey D. Ludwig, Thomas Croce, Carlo M. Coppola, Vincenzo Oncotarget Research Paper Ran Binding Protein 9 (RanBP9, also known as RanBPM) is an evolutionary conserved scaffold protein present both in the nucleus and the cytoplasm of cells whose biological functions remain elusive. We show that active ATM phosphorylates RanBP9 on at least two different residues (S181 and S603). In response to IR, RanBP9 rapidly accumulates into the nucleus of lung cancer cells, but this nuclear accumulation is prevented by ATM inhibition. RanBP9 stable silencing in three different lung cancer cell lines significantly affects the DNA Damage Response (DDR), resulting in delayed activation of key components of the cellular response to IR such as ATM itself, Chk2, γH2AX, and p53. Accordingly, abrogation of RanBP9 expression reduces homologous recombination-dependent DNA repair efficiency, causing an abnormal activation of IR-induced senescence and apoptosis. In summary, here we report that RanBP9 is a novel mediator of the cellular DDR, whose accumulation into the nucleus upon IR is dependent on ATM kinase activity. RanBP9 absence hampers the molecular mechanisms leading to efficient repair of damaged DNA, resulting in enhanced sensitivity to genotoxic stress. These findings suggest that targeting RanBP9 might enhance lung cancer cell sensitivity to genotoxic anti-neoplastic treatment. Impact Journals LLC 2016-03-01 /pmc/articles/PMC4951294/ /pubmed/26943034 http://dx.doi.org/10.18632/oncotarget.7813 Text en Copyright: © 2016 Palmieri et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Palmieri, Dario Scarpa, Mario Tessari, Anna Uka, Rexhep Amari, Foued Lee, Cindy Richmond, Timothy Foray, Claudia Sheetz, Tyler Braddom, Ashley Burd, Christin E. Parvin, Jeffrey D. Ludwig, Thomas Croce, Carlo M. Coppola, Vincenzo Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells |
title | Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells |
title_full | Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells |
title_fullStr | Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells |
title_full_unstemmed | Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells |
title_short | Ran Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells |
title_sort | ran binding protein 9 (ranbp9) is a novel mediator of cellular dna damage response in lung cancer cells |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951294/ https://www.ncbi.nlm.nih.gov/pubmed/26943034 http://dx.doi.org/10.18632/oncotarget.7813 |
work_keys_str_mv | AT palmieridario ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells AT scarpamario ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells AT tessarianna ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells AT ukarexhep ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells AT amarifoued ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells AT leecindy ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells AT richmondtimothy ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells AT forayclaudia ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells AT sheetztyler ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells AT braddomashley ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells AT burdchristine ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells AT parvinjeffreyd ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells AT ludwigthomas ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells AT crocecarlom ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells AT coppolavincenzo ranbindingprotein9ranbp9isanovelmediatorofcellulardnadamageresponseinlungcancercells |